Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications | 12 | 2024 | 345 | 4.110 |
Why?
|
| Breast Feeding | 5 | 2024 | 102 | 3.870 |
Why?
|
| Quality Improvement | 6 | 2024 | 451 | 3.430 |
Why?
|
| Pregnancy | 47 | 2024 | 3018 | 3.350 |
Why?
|
| Stress, Psychological | 12 | 2020 | 322 | 3.250 |
Why?
|
| Counseling | 4 | 2024 | 164 | 3.100 |
Why?
|
| Peer Group | 3 | 2024 | 81 | 2.600 |
Why?
|
| Premature Birth | 12 | 2024 | 117 | 2.570 |
Why?
|
| Perinatal Care | 5 | 2024 | 19 | 2.450 |
Why?
|
| Inflammation | 8 | 2023 | 972 | 2.020 |
Why?
|
| Pregnant Women | 5 | 2020 | 41 | 1.920 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2023 | 75 | 1.850 |
Why?
|
| Pregnancy Outcome | 12 | 2023 | 254 | 1.680 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 101 | 1.660 |
Why?
|
| Infant, Newborn | 23 | 2024 | 2486 | 1.540 |
Why?
|
| Placenta | 6 | 2024 | 179 | 1.530 |
Why?
|
| Prenatal Care | 6 | 2024 | 77 | 1.520 |
Why?
|
| Pregnancy Trimester, Third | 5 | 2020 | 70 | 1.470 |
Why?
|
| Poverty | 3 | 2024 | 180 | 1.410 |
Why?
|
| Cytokines | 5 | 2021 | 803 | 1.380 |
Why?
|
| Postnatal Care | 4 | 2024 | 27 | 1.320 |
Why?
|
| Cooperative Behavior | 2 | 2020 | 179 | 1.280 |
Why?
|
| Mothers | 3 | 2017 | 142 | 1.180 |
Why?
|
| Biomarkers | 9 | 2021 | 1767 | 1.140 |
Why?
|
| Female | 49 | 2024 | 46202 | 1.060 |
Why?
|
| Counselors | 1 | 2024 | 4 | 0.950 |
Why?
|
| Illinois | 8 | 2024 | 480 | 0.940 |
Why?
|
| Birth Certificates | 1 | 2023 | 7 | 0.910 |
Why?
|
| Domestic Violence | 1 | 2023 | 24 | 0.870 |
Why?
|
| United States | 16 | 2024 | 6989 | 0.870 |
Why?
|
| Gestational Age | 7 | 2021 | 329 | 0.870 |
Why?
|
| Hospitals | 3 | 2023 | 299 | 0.860 |
Why?
|
| Adult | 27 | 2024 | 26607 | 0.840 |
Why?
|
| Hydrocortisone | 4 | 2020 | 302 | 0.830 |
Why?
|
| C-Reactive Protein | 4 | 2024 | 192 | 0.770 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2020 | 69 | 0.770 |
Why?
|
| Humans | 52 | 2024 | 89357 | 0.760 |
Why?
|
| Herpesvirus 4, Human | 2 | 2012 | 119 | 0.760 |
Why?
|
| Chorioamnionitis | 2 | 2019 | 21 | 0.750 |
Why?
|
| Prospective Studies | 13 | 2024 | 4289 | 0.750 |
Why?
|
| Perinatology | 1 | 2020 | 14 | 0.740 |
Why?
|
| Fetal Blood | 3 | 2024 | 93 | 0.730 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2018 | 492 | 0.710 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 114 | 0.690 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 35 | 0.680 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 249 | 0.650 |
Why?
|
| Depression | 2 | 2024 | 505 | 0.640 |
Why?
|
| Personality | 1 | 2020 | 134 | 0.640 |
Why?
|
| Medicaid | 4 | 2024 | 232 | 0.630 |
Why?
|
| Antibodies, Viral | 3 | 2018 | 309 | 0.620 |
Why?
|
| Chorionic Villi | 2 | 2019 | 11 | 0.610 |
Why?
|
| Birth Weight | 6 | 2022 | 148 | 0.600 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 78 | 0.590 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 273 | 0.580 |
Why?
|
| Cohort Studies | 8 | 2021 | 2872 | 0.570 |
Why?
|
| Patient Care Team | 1 | 2019 | 284 | 0.560 |
Why?
|
| Placental Circulation | 1 | 2016 | 11 | 0.560 |
Why?
|
| Income | 1 | 2017 | 84 | 0.550 |
Why?
|
| Young Adult | 9 | 2024 | 6312 | 0.540 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 153 | 0.520 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 601 | 0.520 |
Why?
|
| Social Support | 2 | 2017 | 209 | 0.520 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 175 | 0.510 |
Why?
|
| Obstetrics | 1 | 2017 | 123 | 0.510 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 699 | 0.480 |
Why?
|
| Glucocorticoids | 3 | 2021 | 358 | 0.460 |
Why?
|
| Decidua | 1 | 2012 | 19 | 0.430 |
Why?
|
| Health Promotion | 3 | 2024 | 165 | 0.430 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 420 | 0.430 |
Why?
|
| Socioeconomic Factors | 4 | 2017 | 588 | 0.420 |
Why?
|
| Maternal Exposure | 4 | 2023 | 58 | 0.400 |
Why?
|
| Infant, Low Birth Weight | 3 | 2022 | 58 | 0.380 |
Why?
|
| Stress, Physiological | 1 | 2012 | 232 | 0.370 |
Why?
|
| Program Evaluation | 2 | 2024 | 307 | 0.350 |
Why?
|
| Diabetes, Gestational | 2 | 2020 | 40 | 0.340 |
Why?
|
| Women's Health | 1 | 2010 | 102 | 0.340 |
Why?
|
| Principal Component Analysis | 2 | 2021 | 160 | 0.320 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2020 | 81 | 0.310 |
Why?
|
| Logistic Models | 3 | 2021 | 1213 | 0.300 |
Why?
|
| Chronic Disease | 4 | 2021 | 950 | 0.290 |
Why?
|
| Obesity | 4 | 2024 | 971 | 0.250 |
Why?
|
| Glucuronidase | 1 | 2024 | 23 | 0.240 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2015 | 44 | 0.230 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 166 | 0.230 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2015 | 131 | 0.230 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2023 | 7 | 0.230 |
Why?
|
| Focus Groups | 1 | 2024 | 172 | 0.220 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 155 | 0.220 |
Why?
|
| Medical Records | 1 | 2023 | 120 | 0.210 |
Why?
|
| Lipopolysaccharides | 2 | 2021 | 293 | 0.210 |
Why?
|
| Racism | 2 | 2021 | 89 | 0.200 |
Why?
|
| Body Mass Index | 3 | 2024 | 773 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2020 | 158 | 0.190 |
Why?
|
| Risk Factors | 4 | 2020 | 5499 | 0.190 |
Why?
|
| Self Report | 2 | 2015 | 297 | 0.190 |
Why?
|
| Placenta Diseases | 1 | 2021 | 13 | 0.190 |
Why?
|
| Health Status Disparities | 2 | 2021 | 188 | 0.190 |
Why?
|
| Maternal Mortality | 1 | 2021 | 15 | 0.190 |
Why?
|
| Dried Blood Spot Testing | 1 | 2020 | 10 | 0.190 |
Why?
|
| Fetal Development | 2 | 2020 | 31 | 0.190 |
Why?
|
| Mass Screening | 2 | 2023 | 636 | 0.180 |
Why?
|
| Infant | 4 | 2023 | 3160 | 0.180 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2020 | 12 | 0.180 |
Why?
|
| Immunoassay | 1 | 2020 | 91 | 0.180 |
Why?
|
| Postpartum Hemorrhage | 1 | 2020 | 26 | 0.180 |
Why?
|
| Pituitary-Adrenal System | 2 | 2020 | 64 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2023 | 871 | 0.180 |
Why?
|
| Immunity | 1 | 2021 | 141 | 0.180 |
Why?
|
| Adolescent | 4 | 2020 | 9263 | 0.180 |
Why?
|
| Environmental Pollution | 1 | 2019 | 13 | 0.170 |
Why?
|
| Interleukins | 1 | 2020 | 129 | 0.170 |
Why?
|
| Saliva | 2 | 2020 | 124 | 0.170 |
Why?
|
| Leukocytes | 1 | 2020 | 204 | 0.170 |
Why?
|
| Cesarean Section | 1 | 2020 | 142 | 0.170 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 131 | 0.170 |
Why?
|
| Retrospective Studies | 4 | 2021 | 9057 | 0.170 |
Why?
|
| Abortion, Spontaneous | 1 | 2019 | 66 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2020 | 344 | 0.160 |
Why?
|
| Health Behavior | 1 | 2020 | 185 | 0.160 |
Why?
|
| Chicago | 1 | 2023 | 1427 | 0.160 |
Why?
|
| Seasons | 1 | 2019 | 237 | 0.160 |
Why?
|
| Health Equity | 1 | 2020 | 94 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2023 | 29 | 0.150 |
Why?
|
| AIDS Serodiagnosis | 1 | 2018 | 26 | 0.150 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 46 | 0.150 |
Why?
|
| Circadian Rhythm | 2 | 2020 | 305 | 0.150 |
Why?
|
| Drug Monitoring | 1 | 2018 | 119 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 189 | 0.150 |
Why?
|
| Psychology | 1 | 2017 | 24 | 0.140 |
Why?
|
| Parturition | 1 | 2017 | 21 | 0.140 |
Why?
|
| HIV-1 | 1 | 2018 | 166 | 0.140 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2016 | 4 | 0.140 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 3 | 0.140 |
Why?
|
| Adiposity | 1 | 2017 | 76 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 117 | 0.140 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 254 | 0.140 |
Why?
|
| Life Style | 1 | 2017 | 172 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 306 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2016 | 339 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 711 | 0.120 |
Why?
|
| Phenotype | 1 | 2021 | 2440 | 0.120 |
Why?
|
| Infant, Premature | 2 | 2019 | 298 | 0.120 |
Why?
|
| HIV Infections | 2 | 2018 | 840 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1072 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1047 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1714 | 0.110 |
Why?
|
| Transcriptome | 1 | 2017 | 630 | 0.100 |
Why?
|
| Fetal Growth Retardation | 2 | 2023 | 67 | 0.100 |
Why?
|
| Algorithms | 1 | 2019 | 1877 | 0.090 |
Why?
|
| Social Class | 2 | 2022 | 136 | 0.090 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2010 | 55 | 0.090 |
Why?
|
| Residence Characteristics | 2 | 2022 | 202 | 0.090 |
Why?
|
| Reproduction | 1 | 2010 | 199 | 0.080 |
Why?
|
| Middle Aged | 3 | 2016 | 25974 | 0.080 |
Why?
|
| Hospitals, Maternity | 1 | 2007 | 2 | 0.070 |
Why?
|
| Zidovudine | 1 | 2007 | 16 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2015 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 1870 | 0.060 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2024 | 13 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1840 | 0.060 |
Why?
|
| Fetal Death | 1 | 2024 | 57 | 0.060 |
Why?
|
| Child Abuse | 1 | 2024 | 84 | 0.060 |
Why?
|
| Overweight | 1 | 2024 | 119 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 2624 | 0.050 |
Why?
|
| Police | 1 | 2022 | 24 | 0.050 |
Why?
|
| Housing | 1 | 2021 | 45 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2021 | 102 | 0.050 |
Why?
|
| Smoking | 1 | 2024 | 621 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 261 | 0.040 |
Why?
|
| Stillbirth | 1 | 2019 | 10 | 0.040 |
Why?
|
| Live Birth | 1 | 2019 | 17 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1862 | 0.040 |
Why?
|
| Hair | 1 | 2019 | 56 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 75 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 841 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 2019 | 118 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 306 | 0.040 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 46 | 0.040 |
Why?
|
| Placentation | 1 | 2017 | 11 | 0.040 |
Why?
|
| Public Health | 1 | 2018 | 138 | 0.030 |
Why?
|
| Health Policy | 1 | 2018 | 185 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1243 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2884 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2021 | 2017 | 0.030 |
Why?
|
| House Calls | 1 | 2014 | 9 | 0.030 |
Why?
|
| Psychotherapy, Group | 1 | 2014 | 34 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2758 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1976 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 5338 | 0.030 |
Why?
|
| Child | 1 | 2023 | 7174 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 360 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2007 | 280 | 0.020 |
Why?
|
| Male | 1 | 2021 | 42411 | 0.010 |
Why?
|